Saji Vijayan

Former preterm infants are not like babies born at full term. Having been born as early as 24 weeks these infants often go home many weeks before their due date weighing just over 4 pounds and often with multiple ongoing medical needs due to their prematurity. Until now these infants were sent home without additional resources to support their anxious parents who have become accustomed to having their infant monitored 24/7 and immediate access to medical assistance. Predictably, these infants have much higher ER visits and hospital readmissions compared to full term infants. Firstday Healthcare was created by neonatlogists looking to change this status quo and give these infants their best chance to grow safety at home.

Former preterm infants are not like babies born at full term. Having been born as early as 24 weeks these infants often go home many weeks before their due date weighing just over 4 pounds and often with multiple ongoing medical needs due to their prematurity. Until now these infants were sent home without additional resources to support their anxious parents who have become accustomed to having their infant monitored 24/7 and immediate access to medical assistance. Predictably, these infants have much higher ER visits and hospital readmissions compared to full term infants. Firstday Healthcare was created by neonatlogists looking to change this status quo and give these infants their best chance to grow safety at home.

Reliance Life Sciences is a medical biotechnology-led company engaged in research and development, manufacturing and marketing of differentiated medical products and services, used to treat patients primarily in intensive and critical care units in hospitals. Our core businesses are plasma proteins, biosimilars, and later generation oncology pharmaceuticals. In addition, we have initiatives in clinical research, molecular medicine, regenerative medicine, gene therapy, peptides and oligonucleotides.